Frontiers in Oncology

Systematic Review

Published on 31 Jan 2025

Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis

in Hematologic Malignancies

Hongbin Lu
Lulu Luo
Jie Mi
Min Sun
Huaping Wang
Zheng Wang
Wenwen Ding

Frontiers in Oncology

doi 10.3389/fonc.2025.1506799

101 views

Mini Review

Published on 31 Jan 2025

Intracranial germ cell tumors: advancement in genomic diagnostics and the need for novel therapeutics

in Pediatric Oncology

Kee Kiat Yeo
Joanna Gell
Girish Dhall
Ching Lau

Frontiers in Oncology

doi 10.3389/fonc.2025.1513258

106 views

Original Research

Published on 31 Jan 2025

Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yanfang Wang
Hui Liu
Xiang Li
Juan Jin
Bo Yan

Frontiers in Oncology

doi 10.3389/fonc.2025.1521868

173 views

Original Research

Published on 31 Jan 2025

Prognosis of nodal micrometastasis in resectable pN0 non-small cell lung cancer

in Thoracic Oncology

Sophon Siwachat
Apichat Tantraworasin
Nirush Lertprasertsuke
Somcharoen Saeteng

Frontiers in Oncology

doi 10.3389/fonc.2025.1424682

187 views

Original Research

Published on 31 Jan 2025

Risk factors for pelvic lymph node metastasis in cervical cancer: a retrospective analysis of 186 patients

in Gynecological Oncology

Xingyu Sun
Lijuan He
Shaohua Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1525946

158 views

Original Research

Published on 31 Jan 2025

Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer

in Molecular and Cellular Oncology

Chujin Ye
Zhiye Liu
Qifan Xie
Yanlin Tang
Jiayi Zeng
Ziwei Feng
Jiumin Liu
Haibiao Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1443571

109 views

Systematic Review

Published on 31 Jan 2025

Risk factors for lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a systematic review and meta-analysis

in Gastrointestinal Cancers: Colorectal Cancer

Ziyue Chen
Dajian Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1500623

134 views

Correction

Published on 31 Jan 2025

Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

in Cancer Molecular Targets and Therapeutics

Toshio Shimizu
John Powderly
Albiruni Abdul Razak
Patricia LoRusso
Kathy D. Miller
Steven Kao
Sarah Kongpachith
Catherine Tribouley
Michelle Graham
Brian Stoll

Frontiers in Oncology

doi 10.3389/fonc.2024.1544394

106 views

Correction

Published on 31 Jan 2025

Corrigendum: Research progress of breast cancer surgery during 2010–2024: a bibliometric analysis

in Breast Cancer

Jiawei Kang
Nan Jiang
Munire Shataer
Tayier Tuersong

Frontiers in Oncology

doi 10.3389/fonc.2025.1550434

Review

Accepted on 30 Jan 2025

Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer

in Genitourinary Oncology

Brett Wiesen
Hunter A Flores
Paige Hargis
Janet Kukreja

Frontiers in Oncology

doi 10.3389/fonc.2025.1519428

Correction

Accepted on 30 Jan 2025

Corrigendum: Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

in Thoracic Oncology

Lele Huang
Weifang Kong
Yongjun Luo
Hongjun Xie
Jiangyan Liu
Xin Zhang
Guojin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564325

Case Report

Accepted on 30 Jan 2025

Costal Chondrosarcoma in a Woman with Hereditary Multiple Exostoses -A Case Report

in Thoracic Oncology

Ze Yang
Kaiqiang Wang
Jiangtao Pu

Frontiers in Oncology

doi 10.3389/fonc.2025.1469072

Case Report

Accepted on 30 Jan 2025

Repeated misdiagnosis of squamous cell carcinoma of the thyroid: a case report

in Head and Neck Cancer

Yu Zheng
Tingting Ding
Yunsong Peng
Jianyong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1551514

Original Research

Accepted on 30 Jan 2025

The evolving landscape of genetic biomarkers for immunotherapy between primary and metastatic breast cancer

in Breast Cancer

Liang Jin
Zijian Yang
Wei Tang
Pengli Yu
Rongrong Chen
Yan Xu
Jun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1522262

Editorial

Accepted on 30 Jan 2025

Editorial: Non-coding RNAs in Breast Cancer -Volume II

in Cancer Genetics

Wenwen Zhang
Naoyuki Kataoka
Xiaoxiang Guan

Frontiers in Oncology

doi 10.3389/fonc.2025.1561190

Original Research

Accepted on 30 Jan 2025

DETECTION OF RADIOSENSITIVE SUBPOPULATIONS EX-VIVO WITH RAMAN MICROSPECTROSCOPY

in Molecular and Cellular Oncology

Aidan D. Meade
Adrian Maguire
Jane Bryant
Daniel Cullen
Dinesh Medipally
Lisa White
John Armstrong
Mary Dunne
Emma Noone
Shirley Bradshaw

Frontiers in Oncology

doi 10.3389/fonc.2025.1470431

Navigation group

Articles

Prognostic and clinicopathological role of soluble programmed cell death ligand-1 in patients with diffuse large B-cell lymphoma: a meta-analysis

Intracranial germ cell tumors: advancement in genomic diagnostics and the need for novel therapeutics

Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer

Prognosis of nodal micrometastasis in resectable pN0 non-small cell lung cancer

Risk factors for pelvic lymph node metastasis in cervical cancer: a retrospective analysis of 186 patients

Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer

Risk factors for lateral pelvic lymph node metastasis in patients with rectal neuroendocrine tumors: a systematic review and meta-analysis

Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

Corrigendum: Research progress of breast cancer surgery during 2010–2024: a bibliometric analysis

Updated review on novel therapies and ongoing clinical trials for high-risk non-muscle invasive bladder cancer

Corrigendum: Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT images using deep learning

Costal Chondrosarcoma in a Woman with Hereditary Multiple Exostoses -A Case Report

Repeated misdiagnosis of squamous cell carcinoma of the thyroid: a case report

The evolving landscape of genetic biomarkers for immunotherapy between primary and metastatic breast cancer

Editorial: Non-coding RNAs in Breast Cancer -Volume II

DETECTION OF RADIOSENSITIVE SUBPOPULATIONS EX-VIVO WITH RAMAN MICROSPECTROSCOPY